Telomir Pharmaceuticals Common Stock Statistics Share Statistics Telomir Pharmaceuticals Common Stock has 29.76M
shares outstanding. The number of shares has increased by 0.52%
in one year.
Shares Outstanding 29.76M Shares Change (YoY) 0.52% Shares Change (QoQ) 0% Owned by Institutions (%) 12.41% Shares Floating 17.25M Failed to Deliver (FTD) Shares 3,350 FTD / Avg. Volume 0.1%
Short Selling Information The latest short interest is 1.33M, so 4.46% of the outstanding
shares have been sold short.
Short Interest 1.33M Short % of Shares Out 4.46% Short % of Float 6.77% Short Ratio (days to cover) 4.48
Valuation Ratios The PE ratio is -7.36 and the forward
PE ratio is -5.54.
Telomir Pharmaceuticals Common Stock's PEG ratio is
-0.27.
PE Ratio -7.36 Forward PE -5.54 PS Ratio 0 Forward PS 31.1 PB Ratio 189.26 P/FCF Ratio -24 PEG Ratio -0.27
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Telomir Pharmaceuticals Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.94,
with a Debt / Equity ratio of 0.
Current Ratio 1.94 Quick Ratio 1.94 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 2.82
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-16.53M Employee Count 1 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -68.55% in the
last 52 weeks. The beta is -0.66, so Telomir Pharmaceuticals Common Stock's
price volatility has been lower than the market average.
Beta -0.66 52-Week Price Change -68.55% 50-Day Moving Average 1.74 200-Day Moving Average 3.4 Relative Strength Index (RSI) 41.68 Average Volume (20 Days) 3,204,743
Income Statement
Revenue n/a Gross Profit n/a Operating Income -12.24M Net Income -16.53M EBITDA -12.19M EBIT -12.19M Earnings Per Share (EPS) -0.56
Full Income Statement Balance Sheet The company has 1.27M in cash and 0 in
debt, giving a net cash position of 1.27M.
Cash & Cash Equivalents 1.27M Total Debt n/a Net Cash n/a Retained Earnings -30.6M Total Assets 491.19K Working Capital -161.11K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -5.07M
and capital expenditures 0, giving a free cash flow of -5.07M.
Operating Cash Flow -5.07M Capital Expenditures n/a Free Cash Flow -5.07M FCF Per Share -0.17
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
